The systemic inflammatory response syndrome and cardiopulmonary bypass.
about
Lipids, blood pressure and kidney update 2015The science and practice of cardiopulmonary bypass: From cross circulation to ECMO and SIRSNeuroprotective Strategies during Cardiac Surgery with Cardiopulmonary BypassThe puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation.Dual-platform proteomics study of plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass.Pathogenesis and treatment of post-operative cognitive dysfunction.Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trialThe kinetics of cardiopulmonary bypass: a dual-platform proteomics study of plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass.Early administration of levosimendan is associated with improved kidney function after cardiac surgery - a retrospective analysis.Identification of Predictive Early Biomarkers for Sterile-SIRS after Cardiovascular Surgery.In-line Filtration Decreases Systemic Inflammatory Response Syndrome, Renal and Hematologic Dysfunction in Pediatric Cardiac Intensive Care PatientsUlinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass.Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trialMetabolomic profiling in patients undergoing Off-Pump or On-Pump coronary artery bypass surgery.Clinical efficacy of two-phase leukocyte filtration in high-risk patients undergoing coronary revascularization with cardiopulmonary bypassAprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction.Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent.A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia.Pediatric cardiopulmonary bypass: does perfusion mode matter?The potential of the novel leukocyte removal filter in cardiopulmonary bypass.Preoperative asymptomatic leukocytosis and postoperative outcome in cardiac surgery patients.A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass.Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions.Relationship between High Red Cell Distribution Width and Systemic Inflammatory Response Syndrome after Extracorporeal Circulation.Acute systemic inflammatory response after cardiac surgery in patients infected with human immunodeficiency virus using clinical and inflammatory markers.Fluid overload independent of acute kidney injury predicts poor outcomes in neonates following congenital heart surgery.Shed-blood-separation and cell-saver: an integral Part of MiECC? Shed-blood-separation and its influence on the perioperative inflammatory response during coronary revascularization with minimal invasive extracorporeal circulation systems - a randomEffects of propofol and isoflurane on haemodynamics and the inflammatory response in cardiopulmonary bypass surgery.Miniaturized versus conventional cardiopulmonary bypass and acute kidney injury after cardiac surgery.The inflammatory response between miniaturised and conventional cardiopulmonary bypass after cardiac surgery in an Asian population.2017 EACTS Guidelines on perioperative medication in adult cardiac surgery.Safety and efficacy of the perioperative administration of recombinant human brain natriuretic peptide (rhBNP): a systematic review and meta-analysis.Are any biocompatible coatings capable of attenuating the deleterious effects of cardiopulmonary bypass?Intratracheal antitumor necrosis factor-α antibody attenuates lung tissue damage following cardiopulmonary bypass.Extracorporeal membrane oxygenation and cytokine adsorption.Acquired immunological imbalance after surgery with cardiopulmonary bypass due to epigenetic over-activation of PU.1/M-CSF.Development of a novel UHPLC-MS/MS-based platform to quantify amines, amino acids and methylarginines for applications in human disease phenotyping
P2860
Q26771550-3943CF40-839C-40DC-AF5D-3DB51E0907A6Q27014075-AE75F8B4-62D0-45DB-B9C2-12F546CFE7E8Q28076954-65EB22D4-E9FB-443F-B572-165058EF8735Q33351796-43557930-8F5E-46D9-82B7-61891C481861Q33544159-D6170060-E231-4D4F-8F77-2D36D1BC7441Q33620374-9DE68103-B62A-4F09-9FD5-93F435AC26B5Q33793633-522F4E5B-B039-46E9-A7F8-D85F754B7146Q33796490-21D23DD7-2B5D-424A-9DEA-100CEC818FFCQ34129227-55A5E7C3-55C6-4F0F-90FB-D66C8C22987DQ34558248-4193470C-3F7B-4C04-8EB8-DF77AD9D891EQ35742583-C3C7B4C7-0FCB-41A4-B4A1-39346FA0F96CQ35830927-4DF46F72-D355-46D3-8529-1B14594BC0E7Q35865984-90589663-4E50-433F-A12D-9727C92D9FDEQ36209021-FFDF2BEE-34E9-4A73-AF51-EAC20DE7E6EDQ36337156-F69651D7-F519-40D2-8A04-A2B00A40A037Q36374251-D2CDE09F-3A92-4D1A-8212-960ED54933F9Q36588682-101A5652-1337-4F03-B4E6-5A69A60A0046Q36783365-65007989-5693-4D4E-9C1F-E54C168DF04CQ37982834-9E640245-459F-4C79-B0E2-3F9D5F07A526Q38117361-5919F2BF-18C2-4D54-8BD2-B2BF7223F7BFQ38650297-601A71AD-E32A-4C9A-AAA3-9A9C9BBFE3ADQ40066370-DD1C5D19-12BB-43EF-BA60-8842940B1182Q40675871-2CA34607-C0D6-4043-9EE8-288C65E003C6Q41820543-29607E40-244D-498B-A575-5354AE9D11D9Q42364037-BEB5A5A6-B7D7-47D9-A1C2-537FCCFDF82DQ45325494-A2EAC384-E292-477E-BE6F-44A0A027E922Q47219880-A2844C32-A04A-4817-89A2-FB9A1D5553E1Q47249507-12A72990-FD20-4B60-A785-095DA7D8506AQ47633983-16839175-ED8C-42EF-A930-BB43916AECF2Q47715064-9D18B079-1896-4E5F-A6D2-0508B2AC32C3Q47774684-D1A79A3F-4A03-4063-847D-9C431A7DC6F4Q50065204-3D4FFB24-AEA1-4C0D-ABC2-04A8790020CDQ50356199-4344A9C1-14E6-43D1-85EB-7439D2BC424EQ52640529-E2D5BC05-CE51-4CD8-8C87-437298DD52DAQ54275115-74992883-B554-4358-A14E-6F0417DADFF6Q54945544-4E38BE3C-7837-4A34-95F5-4FE52B6D60A0Q55542525-B1E782EA-33BC-4D18-BA7F-C3B59C906606Q58726796-8E796869-338E-4170-B8FA-76BA1BC3AABF
P2860
The systemic inflammatory response syndrome and cardiopulmonary bypass.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The systemic inflammatory response syndrome and cardiopulmonary bypass.
@ast
The systemic inflammatory response syndrome and cardiopulmonary bypass.
@en
type
label
The systemic inflammatory response syndrome and cardiopulmonary bypass.
@ast
The systemic inflammatory response syndrome and cardiopulmonary bypass.
@en
prefLabel
The systemic inflammatory response syndrome and cardiopulmonary bypass.
@ast
The systemic inflammatory response syndrome and cardiopulmonary bypass.
@en
P1476
The systemic inflammatory response syndrome and cardiopulmonary bypass.
@en
P2093
P304
P356
10.1016/J.IJSU.2005.04.002
P407
P577
2005-08-01T00:00:00Z